 Todos Medical Ltd said it has struck an agreement with NLC Pharma to acquire its 3CL protease biology-related assets and form a subsidiary to be known as 3CL Sciences. The subsidiary will focus on developing therapeutics, diagnostics and dietary supplements based on the 3CL protease biology work of Dorit Arad, who will be appointed chief scientific officer of the new company. 